nimodipine has been researched along with Coronary Heart Disease in 4 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| " An increasing dosage of nimodipine is accompanied by increasing cardiovascular effects." | 2.66 | [Hemodynamic effects in high-dose infusion of nimodipine, a new calcium antagonist]. ( Boldt, J; Hempelmann, G; Kling, D; Moosdorf, R; Ratthey, K; von Bormann, B, 1986) |
| "03 mg/kg bwxh nimodipine, a dosage being used in neurosurgery, can be classified as safe." | 2.66 | [Hemodynamic changes in infusion with nimodipine]. ( Boldt, J; Görlach, G; Hempelmann, G; Kling, D; von Bormann, B, 1985) |
| "Brain damage after resuscitation from cardiac arrest is believed to be related to calcium influx in ischaemic neurons and to postischaemic calcium-dependent vasospasm." | 1.28 | Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat. ( Bogaert, MG; Buylaert, WA; Calle, PA; De Ridder, L, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roine, RO | 1 |
| Calle, PA | 1 |
| Bogaert, MG | 1 |
| De Ridder, L | 1 |
| Buylaert, WA | 1 |
| Boldt, J | 2 |
| von Bormann, B | 2 |
| Kling, D | 2 |
| Ratthey, K | 1 |
| Moosdorf, R | 1 |
| Hempelmann, G | 2 |
| Görlach, G | 1 |
2 trials available for nimodipine and Coronary Heart Disease
| Article | Year |
|---|---|
[Hemodynamic effects in high-dose infusion of nimodipine, a new calcium antagonist].
Topics: Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Hemodynamics; Humans; Hy | 1986 |
[Hemodynamic changes in infusion with nimodipine].
Topics: Anesthesia, General; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Dose-Respon | 1985 |
2 other studies available for nimodipine and Coronary Heart Disease
| Article | Year |
|---|---|
Nimodipine in patients with heart disease.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cerebrovascular Disorders; Clinical Trials as Top | 1996 |
Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.
Topics: Animals; Blood Pressure; Cell Survival; Coronary Disease; Disease Models, Animal; Electrocardiograph | 1990 |